Sema4D was highly expressed in B-ALL, T-ALL, and AML patients compared with healthy children (Figures 1(a) and 1(b)); Sema4D expression was significantly higher in T-ALL patients than in B-ALL or AML patients (Figure 1(b)). This evidence concerns the gene SEMA4D and acute lymphoblastic leukemia.